Neximmune Stock Market Value
| NEXI Stock | USD 0.0001 0.00 0.00% |
| Symbol | Neximmune |
Neximmune 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Neximmune's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Neximmune.
| 12/12/2025 |
| 01/11/2026 |
If you would invest 0.00 in Neximmune on December 12, 2025 and sell it all today you would earn a total of 0.00 from holding Neximmune or generate 0.0% return on investment in Neximmune over 30 days. NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for pat... More
Neximmune Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Neximmune's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Neximmune upside and downside potential and time the market with a certain degree of confidence.
Neximmune Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Neximmune's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Neximmune's standard deviation. In reality, there are many statistical measures that can use Neximmune historical prices to predict the future Neximmune's volatility.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Neximmune's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Neximmune Backtested Returns
We have found three technical indicators for Neximmune, which you can use to evaluate the volatility of the firm. The company secures a Beta (Market Risk) of 0.0, which conveys not very significant fluctuations relative to the market. the returns on MARKET and Neximmune are completely uncorrelated.
Auto-correlation | 0.00 |
No correlation between past and present
Neximmune has no correlation between past and present. Overlapping area represents the amount of predictability between Neximmune time series from 12th of December 2025 to 27th of December 2025 and 27th of December 2025 to 11th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Neximmune price movement. The serial correlation of 0.0 indicates that just 0.0% of current Neximmune price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Neximmune lagged returns against current returns
Autocorrelation, which is Neximmune pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Neximmune's pink sheet expected returns. We can calculate the autocorrelation of Neximmune returns to help us make a trade decision. For example, suppose you find that Neximmune has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Neximmune regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Neximmune pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Neximmune pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Neximmune pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Neximmune Lagged Returns
When evaluating Neximmune's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Neximmune pink sheet have on its future price. Neximmune autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Neximmune autocorrelation shows the relationship between Neximmune pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Neximmune.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Neximmune Pink Sheet
Neximmune financial ratios help investors to determine whether Neximmune Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Neximmune with respect to the benefits of owning Neximmune security.